Curtiss-Wright (CW) CFO sells 918 shares after RSU vesting

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Curtiss-Wright Executive VP and CFO Christopher K. Farkas reported the vesting of restricted stock units and a related share sale. On March 16, 2026, 2,183 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested into common stock with no exercise price as an employee benefit.

Following vesting, he held 6,436 common shares, then on March 17, 2026 he sold 918 common shares in open-market transactions at an average price of $677.46 per share. The sale was made to cover tax obligations associated with the vesting, in line with company share ownership guidelines, and left him with 5,518 common shares and 9,366 restricted stock units, including dividend credits.

Insider Trade Summary

Net Seller: 918 shares ($621,908)

Net Sell 3 txns

Insider Farkas K Christopher

Role Executive VP and CFO

Sold 918 shs ($622K)

Type	Security	Shares	Price	Value
Sale	Common Stock	918	$677.46	$622K
Exercise	Restricted Stock Unit	2,183	$0.00	--
Exercise	Common Stock	2,183	$0.00	--

Holdings After Transaction: Common Stock — 5,518 shares (Direct); Restricted Stock Unit — 9,366 shares (Direct)

Footnotes (1)

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction. Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price. Share total includes dividend credits earned on prior outstanding grants.

Form 4 Insider Transactions: What Each Field Means →

03/18/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farkas K Christopher

(Last)

(First)

(Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON

NORTH CAROLINA

28036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive VP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/16/2026		M⁽¹⁾		2,183	A	$0⁽²⁾	6,436	D
Common Stock	03/17/2026		S⁽³⁾		918	D	$677.46⁽⁴⁾	5,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	$0⁽²⁾	03/16/2026		M⁽¹⁾			2,183	03/16/2026	03/16/2026	Common Stock	2,183	$0⁽²⁾	9,366⁽⁵⁾	D

Explanation of Responses:

1. These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

2. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

3. Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

4. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

5. Share total includes dividend credits earned on prior outstanding grants.

Remarks:

	George P. McDonald by Power of Attorney from K. Christopher Farkas	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Curtiss-Wright (CW) CFO Christopher Farkas report?

Christopher Farkas reported RSU vesting and a related stock sale. 2,183 restricted stock units vested into common stock, and he sold 918 common shares in open-market transactions at an average price of $677.46 per share, primarily to address tax obligations.

How many Curtiss-Wright (CW) shares did the CFO sell and at what price?

The CFO sold 918 shares of Curtiss-Wright common stock. The reported average selling price was $677.46 per share, with multiple trades executed in a price range from $669.72 to $681.43, according to the detailed transaction footnote.

What RSU vesting did Curtiss-Wright (CW) disclose for its CFO?

Curtiss-Wright disclosed that 2,183 restricted stock units granted on March 16, 2023 to the CFO vested on March 16, 2026. These RSUs, granted under the 2014 Omnibus Incentive Plan, converted into common stock at no cost as an employee benefit transaction.

Why did the Curtiss-Wright (CW) CFO sell shares after RSU vesting?

The filing states the CFO sold shares to cover tax obligations from the RSU vesting. The company notes these sales comply with its share ownership guidelines and confirms the reporting person remains in compliance with those guidelines after completing the transactions.

What are the Curtiss-Wright (CW) CFO’s holdings after these transactions?

After the reported transactions, the CFO holds 5,518 shares of Curtiss-Wright common stock directly. He also holds 9,366 restricted stock units, with that RSU total noted as including dividend credits earned on prior outstanding grants, based on the filing footnote.

Were the Curtiss-Wright (CW) CFO’s RSUs granted at a purchase price?

The RSUs were granted with no purchase price on the date of issue. The filing explains that the restricted stock units were awarded as an employee benefit transaction under Curtiss-Wright’s 2014 Omnibus Incentive Plan, rather than acquired through an open-market purchase.